This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Myers, R. E. Articles by Chodak, G. W. Search for Related Content PubMed PubMed Citation Articles by Myers, R. E. Articles by Chodak, G. W.

Intention to Be Tested for Prostate Cancer Risk among African-American Men¹

Behavioral Epidemiology Section, Division of Medical Oncology and Medical Genetics [R. E. M., T. A. W., D. Y. B., J. A. D.], and Biostatistics Section, Division of Clinical Pharmacology [T. H.], Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107; College of Nursing and Health Professions, MCP Hahnemann University, Philadelphia, Pennsylvania 19102 [K. J-D.]; Georgetown University Medical Center, Washington DC 20007-4104 [C. L.]; and Weiss Memorial Hospital, Chicago, Illinois 60640 [G. W. C.]

This study was conducted to identify factors associated with intention to be tested for prostate cancer risk among African-American men. Participants in this study included African-American men (n = 548) who were patients at the University Health Service at the University of Chicago, were 40 to 70 years of age, and did not have a personal history of prostate cancer. Baseline telephone survey data were collected for 413 (75%) men. Respondents were asked if they intended to have a blood test to assess prostate cancer risk. Univariate and multivariate analyses of intention to be tested for risk were performed. Eighty-six percent of the men said that they intended to be tested. Multivariate analysis results show that belief in the efficacy of prostate cancer screening [odds ratio (OR) = 3.6; 95% confidence interval (CI) = 1.4, 9.1] and intention to undergo a prostate cancer-screening (i.e., digital rectal examination and prostate-specific antigen testing; OR = 2.8; 95% CI = 1.3, 6.3) were positively associated with intention to be tested for prostate cancer risk. Being older (OR = 0.4; 95% CI = 0.2, 0.9), having had a prostate cancer-screening examination in the past year (OR = 0.5; 95% CI = 0.2, 1.0), perceiving one’s prostate cancer susceptibility to be high (OR = 0.4; 95% CI = 0.2, 0.8), and being fatalistic about prostate cancer prevention (OR = 0.3; 95% CI = 0.2, 0.7) were negatively associated with intention to be tested for risk. Intention to be tested for prostate cancer risk was high among men in the study. Past screening, perceived susceptibility, and beliefs related to early detection might influence receptivity to genetic testing for prostate cancer risk.

This article has been cited by other articles:

				N. S. Consedine, B. A. Adjei, P. M. Ramirez, and J. M. McKiernan An Object Lesson: Source Determines the Relations That Trait Anxiety, Prostate Cancer Worry, and Screening Fear Hold with Prostate Screening Frequency Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1631 - 1639. [Abstract] [Full Text] [PDF]

				D. Reynolds Prostate Cancer Screening in African American Men: Barriers and Methods for Improvement American Journal of Men's Health, June 1, 2008; 2(2): 172 - 177. [Abstract] [PDF]

				A. G Papatsoris and F. Anagnostopoulos Men's behaviour towards prostate cancer screening Postgrad. Med. J., February 1, 2008; 84(988): 57 - 59. [Full Text] [PDF]

				N. S. Consedine, D. Horton, T. Ungar, A. K. Joe, P. Ramirez, and L. Borrell Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men American Journal of Men's Health, March 1, 2007; 1(1): 29 - 43. [Abstract] [PDF]

				P. K.J. Han, S. C. Kobrin, W. M.P. Klein, W. W. Davis, M. Stefanek, and S. H. Taplin Perceived Ambiguity about Screening Mammography Recommendations: Association with Future Mammography Uptake and Perceptions Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 458 - 466. [Abstract] [Full Text] [PDF]

				J. R. Bloom, S. L. Stewart, I. Oakley-Girvans, P. J. Banks, and S. Chang Family History, Perceived Risk, and Prostate Cancer Screening among African American Men. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2167 - 2173. [Abstract] [Full Text] [PDF]

				N. S. Consedine, A. H. Morgenstern, E. Kudadjie-Gyamfi, C. Magai, and A. I. Neugut Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 228 - 237. [Abstract] [Full Text] [PDF]

				C. H. Halbert, O. H. Gandy Jr., A. Collier, and L. Shaker Intentions to Participate in Genetics Research among African American Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 150 - 153. [Abstract] [Full Text] [PDF]

				E. J. S. Kunkel, B. Meyer, C. Daskalakis, J. Cocroft, K. Jennings-Dozier, and R. E. Myers Behaviors Used by Men to Protect Themselves against Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 78 - 86. [Abstract] [Full Text] [PDF]